The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders
Open accessAbstract
The European Myeloma Network (EMN) organized two flow cytometry workshops. The first aimed to identify specific indications for flow cytometry in patients with monoclonal gammopathies, and consensus technical approaches through a questionnaire-based review of current practice in participating laboratories. The second aimed to resolve outstanding technical issues and develop a consensus approach to analysis of plasma cells. The primary clinical applications identified were: differential diagnosis of neoplastic plasma cell disorders from reactive plasmacytosis; identifying risk of progression in patients with MGUS and detecting minimal residual disease. A range of technical recommendations were identified, including: 1) CD38, CD138 and CD45 should all be included in at least one tube for plasma cell identification and enumeration. The primary gate should be based on CD38 vs. CD138 expression; 2) after treatment, clonality assessment is only likely to be informative when combined with immunophenotype to detect abnormal cells. Flow cytometry is suitable for demonstrating a stringent complete remission; 3) for detection of abnormal plasma cells, a minimal panel should include CD19 and CD56. A preferred panel would also include CD20, CD117, CD28 and CD27; 4) discrepancies between the percentage of plasma cells detected by flow cytometry and morphology are primarily related to sample quality and it is, therefore, important to determine that marrow elements are present in follow-up samples, particularly normal plasma cells in MRD negative cases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
World Health Organization Classification of Tumours
Fletcher, C., van den Berg, A., & Molenaar, I. (2002) · Cited by 7,079
Hossfeld, D. K. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf146 · Cited by 4,625
International uniform response criteria for multiple myeloma
Durie, B. G. M., Harousseau, J.-L., Miguel, J. S., Bladé, J., Barlogie, B., Anderson, K., Gertz, M., Dimopoulos, M., Westin, J., Sonneveld, P., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404284 · Cited by 2,632
Self-citationThe International Myeloma Working Group (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04355.x · Cited by 2,321
Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues
Jaffe, E. S. (2003) · Cited by 2,141
BladÉ, J., Samson, D., Reece, D., Apperley, J., BJÖrkstrand, B., Gahrton, G., Gertz, M., Giralt, S., Jagannath, S., Vesole, D., et al. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00930.x · Cited by 1,519
Owen, R. G., Treon, S. P., Al-Katib, A., Fonseca, R., Greipp, P. R., McMaster, M. L., Morra, E., Pangalis, G. A., San Miguel, J. F., Branagan, A. R., et al. (2003) · Seminars in Oncology · doi:10.1053/sonc.2003.50082 · Cited by 924
Self-citationPérez-Persona, E., Vidriales, M.-B., Mateo, G., García-Sanz, R., Mateos, M.-V., de Coca, A. G., Galende, J., Martín-Nuñez, G., Alonso, J. M., de las Heras, N., et al. (2007) · Blood · doi:10.1182/blood-2007-05-088443 · Cited by 579
Self-citationFlow Cytometric Immunophenotypic Analysis of 306 Cases of Multiple Myeloma
Lin, P. Y., Owens, R., Tricot, G. J. K., & Wilson, C. S. (2004) · American Journal of Clinical Pathology · doi:10.1309/74r4-tb90-buwh-27jx · Cited by 454
Rawstron, A. C., Villamor, N., Ritgen, M., Böttcher, S., Ghia, P., Zehnder, J. L., Lozanski, G., Colomer, D., Moreno, C., Geuna, M., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404584 · Cited by 403
Self-citationPhenotypic difference of normal plasma cells from mature myeloma cells
Harada, H., Kawano, M., Huang, N., Harada, Y., Iwato, K., Tanabe, O., Tanaka, H., Sakai, A., Asaoku, H., & Kuramoto, A. (1993) · Blood · doi:10.1182/blood.v81.10.2658.2658 · Cited by 355
San Miguel, J. F., Vidriales, M. B., López-Berges, C., Dı́az-Mediavilla, J., Gutiérrez, N., Cañizo, C., Ramos, F., Calmuntia, M. J., Pérez, J. J., González, M., et al. (2001) · Blood · doi:10.1182/blood.v98.6.1746 · Cited by 335
Self-citationCoustan-Smith, E., Sancho, J., Behm, F. G., Hancock, M. L., Razzouk, B. I., Ribeiro, R. C., Rivera, G. K., Rubnitz, J. E., Sandlund, J. T., Pui, C.-H., et al. (2002) · Blood · doi:10.1182/blood-2002-01-0006 · Cited by 272
Ocqueteau, M. E., Orfao, A., Almeida, J., Bladé, J., González, M., García‐Sánz, R., López-Berges, C., Moro, M., Hernández‐Rivas, J. M., Escribano, L., et al. (1998) · Europe PMC (PubMed Central) · Cited by 256
Self-citationNowakowski, G. S., Witzig, T. E., Dingli, D., Tracz, M. J., Gertz, M. A., Lacy, M. Q., Lust, J. A., Dispenzieri, A., Greipp, P. R., Kyle, R. A., et al. (2005) · Blood · doi:10.1182/blood-2005-05-1858 · Cited by 245
Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells
Pellat-Deceunynck, C., Bataille, R., Robillard, N., Harousseau, J., Rapp, M., Juge- Morineau, N., Wijdenes, J., & Amiot, M. (1994) · Blood · doi:10.1182/blood.v84.8.2597.2597 · Cited by 214
Self-citationRawstron, A. C., Davies, F. E., DasGupta, R., Ashcroft, A. J., Patmore, R., Drayson, M. T., Owen, R. G., Jack, A. S., Child, J. A., & Morgan, G. J. (2002) · Blood · doi:10.1182/blood-2001-12-0297 · Cited by 210
Self-citationCD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma
Robillard, N., Avet-Loiseau, H., Garand, R., Moreau, P., Pineau, D., Rapp, M.-J., Harousseau, J.-L., & Bataille, R. (2003) · Blood · doi:10.1182/blood-2002-11-3333 · Cited by 184
Sarasquete, M. E., García‐Sánz, R., González, D., Martínez‐López, J., Mateo, G., Martı́nez, P., Ribera, J., Hernández, J. M., Lahuerta, J. J., Órfão, A., et al. (2005) · PubMed · Cited by 181
Self-citationMartinelli, G., Terragna, C., Zamagni, E., Ronconi, S., Tosi, P., Lemoli, R. M., Bandini, G., Motta, M. R., Testoni, N., Amabile, M., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.11.2273 · Cited by 166
Barrena, S., Almeida, J., Yunta, M., López, A., Fernández-Mosteirín, N., Giralt, M., Romero, M., Perdiguer, L., Delgado, M., Orfao, A., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2403822 · Cited by 165
Self-citationSan Miguel, J. F., Almeida, J., Mateo, G., Bladé, J., López-Berges, C., Caballero, D., Hernández, J., Moro, M. J., Fernández-Calvo, J., Dı́az-Mediavilla, J., et al. (2002) · Blood · doi:10.1182/blood.v99.5.1853 · Cited by 160
Self-citationEscribano, L., Díaz-Agustín, B., López, A., Núñez, R., García‐Montero, A. C., Almeida, J., Prados, A., Angulo, M., Herrero, S., Órfão, A., et al. (2004) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.10072 · Cited by 148
Pellat‐Deceunynck, C., Barillé‐Nion, S., Puthier, D., Rapp, M. J., Harousseau, J., Bataille, R., & Amiot, M. (1995) · PubMed · Cited by 145
Self-citationTreon, S. P., Pilarski, L. M., Belch, A. R., Kelliher, A. S., Preffer, F. I., Shima, Y., Mitsiades, C. S., Mitsiades, N., Szczepek, A. J., Ellman, L. L., et al. (2002) · Journal of Immunotherapy · doi:10.1097/00002371-200201000-00008 · Cited by 133
Bone marrow histology in myeloma: its importance in diagnosis, prognosis, classification and staging
Bartl, R., Frisch, B., Burkhardt, R., Moghadam, A. F., Mahl, G., Gierster, P., Sund, M., & Kettner, G. (1982) · British Journal of Haematology · doi:10.1111/j.1365-2141.1982.00361.x · Cited by 130
Bone marrow histology in myeloma: its importance in diagnosis, prognosis, classification and staging
Bartl, R., Frisch, B., Burkhardt, R., Fateh-Moghadam, A., Mahl, G., Gierster, P., Sund, M., & Kettner, G. (1982) · British Journal of Haematology · doi:10.1111/j.1365-2141.1982.tb02791.x · Cited by 116
Davies, F. E., Forsyth, P. D., Rawstron, A. C., Owen, R. G., Pratt, G., Evans, P., Richards, S. J., Drayson, M. T., Smith, G., Selby, P. J., et al. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02530.x · Cited by 111
Self-citationDifferential expression of CD56 and CD44 in the evolution of extramedullary myeloma
Dahl, I. M. S., Rasmussen, T., Kaurić, G., & Husebekk, A. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03258.x · Cited by 102
Diagnosis and management of multiple myeloma
(2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03206.x · Cited by 101
Prognostic implications of DNA aneuploidy in 156 untreated multiple myeloma patients
García‐Sánz, R., ORFAO, A., González, M., et al. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb03387.x · Cited by 80
Self-citationBakkus, M. H. C., Bouko, Y., Samson, D., Apperley, J. F., Thielemans, K., Camp, B. V., Benner, A., Goldschmidt, H., Moos, M., & Cremer, F. W. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05120.x · Cited by 79
Phenotypic characterization of the human myeloma cell growth fraction
Robillard, N., Pellat‐Deceunynck, C., & Bataille, R. (2005) · Blood · doi:10.1182/blood-2004-12-4700 · Cited by 68
Self-citationDiagnosis and Management of Multiple Myeloma
Ely, S. A. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.37006.x · Cited by 63
Lack of CD27 in myeloma delineates different presentation and outcome
Moreau, P., Robillard, N., Jégo, G., Pellat‐Deceunynck, C., Gouill, S. L., Thoumi, S., Avet‐Loiseau, H., Harousseau, J., & Bataille, R. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05849.x · Cited by 60
Self-citationGalimberti, S., Benedetti, E., Morabito, F., Papineschi, F., Callea, V., Fazzi, R., Stelitano, C. C., Andreazzoli, F., Guerrini, F., Ciabatti, E., et al. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.01.017 · Cited by 57
Bone marrow immunohistology of plasma cell neoplasms
Wei, A. H., & Juneja, S. (2003) · Journal of Clinical Pathology · doi:10.1136/jcp.56.6.406 · Cited by 54
Rasmussen, T., Poulsen, T. S., Honoré, L., & Johnsen, H. E. (2000) · Experimental Hematology · doi:10.1016/s0301-472x(00)00514-2 · Cited by 51
Self-citationTerpstra, W. E., Lokhorst, H. M., Blomjous, F. J. E. M., Meuwissen, O. J., & Dekker, A. W. (1992) · British Journal of Haematology · doi:10.1111/j.1365-2141.1992.tb04592.x · Cited by 50
Immunophenotyping of Plasma Cells in Multiple Myeloma
Manzanera, G. M., Miguel, J. F. S., & de Matos, A. O. (2005) · Humana Press eBooks · doi:10.1385/1-59259-916-8:5 · Cited by 39
Vídriales, M., & Anderson, K. C. (1996) · Molecular Medicine Today · doi:10.1016/1357-4310(96)84846-5 · Cited by 31
Swedin, A., Lenhoff, S., Olofsson, T., Thuresson, B., & Westin, J. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.01075.x · Cited by 26
CD52 expression patterns in myeloma and the applicability of alemtuzumab therapy.
Rawstron, A. C., Laycock-Brown, G., Hale, G., et al. (2006) · PubMed · Cited by 11
Self-citation
Cited by
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
Rajkumar, S. V., Dimopoulos, M. A., Palumbo, A., Blade, J., Merlini, G., Mateos, M.-V., Kumar, S., Hillengass, J., Kastritis, E., Richardson, P., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70442-5 · Cited by 4,978
Self-citationKumar, S., Paiva, B., Anderson, K. C., Durie, B., Landgren, O., Moreau, P., Munshi, N., Lonial, S., Bladé, J., Mateos, M.-V., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30206-6 · Cited by 3,061
Self-citationGuidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Cossarizza, A., Chang, H., Radbruch, A., Acs, A., Adam, D., Adam‐Klages, S., Agace, W. W., Aghaeepour, N., Akdis, M., Allez, M., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201970107 · Cited by 979
Self-citationon behalf of the EuroFlow Consortium (EU-FP6, L.-C.-2.-0., van Dongen, J. J. M., Lhermitte, L., Böttcher, S., Almeida, J., van der Velden, V. H. J., Flores-Montero, J., Rawstron, A., Asnafi, V, Lécrevisse, Q., et al. (2012) · Leukemia · doi:10.1038/leu.2012.120 · Cited by 934
Self-citationEuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols
on behalf of the EuroFlow Consortium (EU-FP6, L.-C.-2.-0., Kalina, T., Flores-Montero, J., van der Velden, V. H. J., Martin-Ayuso, M., Böttcher, S., Ritgen, M., Almeida, J., Lhermitte, L., Asnafi, V, et al. (2012) · Leukemia · doi:10.1038/leu.2012.122 · Cited by 783
Self-citation
Metadata
- Authors
- Rawstron, A. C., Orfao, A., Beksac, M., Bezdickova, L., Brooimans, R. A., Bumbea, H., Dalva, K., Fuhler, G., Gratama, J., Hose, D., Kovarova, L., Lioznov, M., Mateo, G., Morilla, R., Mylin, A. K., Omede, P., Pellat-Deceunynck, C., Andres, M. P., Petrucci, M., Ruggeri, M., Rymkiewicz, G., Schmitz, A., Schreder, M., Seynaeve, C., Spacek, M., de Tute, R. M., Van Valckenborgh, E., Weston-Bell, N., Owen, R. G., San Miguel, J. F., Sonneveld, P., Johnsen, H. E., & on behalf of the European Myeloma Network
- Venue
- Haematologica
- Published
- 2008-03-01
- Volume
- 93
- Issue
- 3
- Pages
- 431-438
- ISSN
- 0390-6078 (ISSN-L)
- 1592-8721
- OpenAlex
- W2165574508
- Cited by
- 513
- References
- 43
- FWCI
- 15.26
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.